This irreversible disability in patients with cognitive impairment may be secondary to their higher IgG1-LGI1 antibodies, with subsequent complement deposition and ensuing hippocampal atrophy (Bien et al., 2007, 2012; Ariño et al., 2016; Finke et al., 2017). Here, LGI1 is linked to hippocampal atrophy.